Abayasingam A; Balachandran H; Agapiou D; Hammoud M; Rodrigo C; Keoshkerian E; Li H; Brasher NA; Christ D; Rouet R; Burnet D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Stella AO; Fichter C; Brilot F; Mina M; Post JJ; Hudson B; Gilroy N; Dwyer D; Sasson SC; Tea F; Pilli D; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, 2021, 'Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection', Cell Reports Medicine, pp. 100228, http://dx.doi.org/10.1016/j.xcrm.2021.100228
Wu BR; Eltahla AA; Keoshkerian E; Walker MR; Underwood A; Brasher NA; Agapiou D; Lloyd AR; Bull RA, 2019, 'A method for detecting hepatitis C envelope specific memory B cells from multiple genotypes using cocktail E2 tetramers', Journal of Immunological Methods, vol. 472, pp. 65 - 74, http://dx.doi.org/10.1016/j.jim.2019.06.016
Moalem-Taylor G; Baharuddin B; Bennett B; Krishnan AV; Huynh W; Kiernan MC; Shin-Yi Lin C; Shulruf B; Keoshkerian E; Cameron B; Lloyd A, 2017, 'Immune dysregulation in patients with carpal tunnel syndrome', Scientific Reports, vol. 7, http://dx.doi.org/10.1038/s41598-017-08123-6
Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J; Kelleher A; Lloyd AR; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Luciani F, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, vol. 23, pp. 985 - 993, http://dx.doi.org/10.1111/jvh.12576
Lamoury FMJ; Hajarizadeh B; Keoshkerian E; Feld JJ; Amin J; Teutsch S; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Applegate TL; Grebely J, 2016, 'HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection', BMC Infectious Diseases, vol. 16, http://dx.doi.org/10.1186/s12879-016-1567-2
Hajarizadeh B; Lamoury FMJ; Feld JJ; Amin J; Keoshkerian E; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection', Virology Journal, vol. 13, http://dx.doi.org/10.1186/s12985-016-0482-x
Marsden V; Donaghy H; Bertram KM; Harman AN; Nasr N; Keoshkerian E; Merten S; Lloyd AR; Cunningham AL, 2015, 'Herpes simplex virus type 2-infected dendritic cells produce TNF-α, which enhances CCR5 expression and stimulates HIV production from adjacent infected cells', Journal of Immunology, vol. 194, pp. 4438 - 4445, http://dx.doi.org/10.4049/jimmunol.1401706
Nguyen N; Luciani F; Cameron B; Keoshkerian E; Zekry A; Lloyd A, 2012, '801 T CELLS CO-EXPRESSING CCR2, CCR5, CXCR3, AND CXCR6 ARE PREFERENTIALLY ENRICHED IN THE HCV-INFECTED LIVER', Journal of Hepatology, vol. 56, pp. S313 - S313, http://dx.doi.org/10.1016/s0168-8278(12)60813-7
Kelleher AD; Puls R; Bebbington M; Boyle D; Kent S; Kippax SC; Purcell D; Thomson S; Wand HC; Cooper DA; Emery S; Ffrench RA, 2006, 'A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1', AIDS, vol. 20, pp. 294 - 297, http://dx.doi.org/10.1097/01.aids.0000199819.40079.e9
Chen K; Chen L; Zhao P; Marrero L; Keoshkerian E; Ramsay A; Cui Y, 2005, 'FL-CTL assay: Fluorolysometric determination of cell-mediated cytotoxicity using green fluorescent protein and red fluorescent protein expressing target cells', Journal of Immunological Methods, vol. 300, pp. 100 - 114, http://dx.doi.org/10.1016/j.jim.2005.02.010
Keoshkerian E; Happel KI; Lockhart EA; Mason CM; Poretta E; Odden AR; Nelson S; Ramsay AJ, 2005, 'Pulmonary interlukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs.', Infectious Immunology, vol. 73, pp. 5782 - 5788
Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench R, 2003, 'Effector HIV-specific cytotoxic T lymphocyte activity in HIV non-progressors correlates with viral replication and progression', Journal of Medical Virology, vol. 71, pp. 483 - 491, http://dx.doi.org/10.1002/jmv.10525
Hicks C; Keoshkerian E; Gaudry L; Lindeman R, 2001, 'CD80 (B7-1) expression on human acute myeloid leukaemic cells cultured with GM-CSF, IL-3 and IL-6', Cancer Immunology, Immunotherapy, vol. 50, pp. 173 - 180, http://dx.doi.org/10.1007/PL00006686
Keoshkerian E; Hicks C; Lindeman R, 2001, 'Adenoviral mediated IL-2 gene transfer to human long-term bone marrow stromal cultures.', Cancer Biotherapy and Radiopharmaceuticals, vol. 16, pp. 537 - 542, http://dx.doi.org/10.1089/10849780152752137
Keoshkerian E; Hicks C; Gaudry L; Lindeman R, 2000, 'B7.1 (CD80) expression on human acute myeloid leukaemia cells cultured with GM-CSF, IL-3, and IL-6.', Cancer Immunology and Immunotherapy, vol. 50, pp. 173 - 180
Minter AJ; Keoshkerian E; Chesterman CN; Dawes J, 1996, 'Fibroblast growth factor and heparin protect endothelial cells from the effects of interleukin 1', Journal of Cellular Physiology, vol. 167, pp. 229 - 237, http://dx.doi.org/10.1002/(SICI)1097-4652(199605)167:2<229::AID-JCP6>3.0.CO;2-R
